119 related articles for article (PubMed ID: 16321809)
1. Antiphospholipid antibodies and platelet activation as risk factors for thrombosis in thrombocythaemia.
Bidot CJ; Jy W; Horstman LL; Ahn ER; Bidot L; Fontana V; Ahn YS
Hematology; 2005 Dec; 10(6):451-6. PubMed ID: 16321809
[TBL] [Abstract][Full Text] [Related]
2. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies.
Jy W; Tiede M; Bidot CJ; Horstman LL; Jimenez JJ; Chirinos J; Ahn YS
Thromb Res; 2007; 121(3):319-25. PubMed ID: 17582471
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS).
Bidot CJ; Jy W; Horstman LL; Ahn ER; Yaniz M; Ahn YS
Am J Hematol; 2006 Jun; 81(6):391-6. PubMed ID: 16680753
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid antibodies in immune thrombocytopenic purpura tend to emerge in exacerbation and decline in remission.
Bidot CJ; Jy W; Horstman LL; Ahn ER; Jimenez JJ; Yaniz M; Lander G; Ahn YS
Br J Haematol; 2005 Feb; 128(3):366-72. PubMed ID: 15667539
[TBL] [Abstract][Full Text] [Related]
5. Factor VII/VIIa: a new antigen in the anti-phospholipid antibody syndrome.
Bidot CJ; Jy W; Horstman LL; Huisheng H; Jimenez JJ; Yaniz M; Ahn YS
Br J Haematol; 2003 Feb; 120(4):618-26. PubMed ID: 12588348
[TBL] [Abstract][Full Text] [Related]
6. Receptors involved in cell activation by antiphospholipid antibodies.
Brandt KJ; Kruithof EK; de Moerloose P
Thromb Res; 2013 Oct; 132(4):408-13. PubMed ID: 24054056
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Antiphospholipid Antibodies in Patients With Immune Thrombocytopenia and Correlation With Treatment With Steroids in North Indian Population.
Dayama A; Dass J; Mahapatra M; Saxena R
Clin Appl Thromb Hemost; 2017 Sep; 23(6):657-662. PubMed ID: 27067744
[TBL] [Abstract][Full Text] [Related]
8. LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers.
Ochoa E; Iriondo M; Manzano C; Fullaondo A; Villar I; Ruiz-Irastorza G; Zubiaga AM; Estonba A
PLoS One; 2016; 11(1):e0146990. PubMed ID: 26820623
[TBL] [Abstract][Full Text] [Related]
9. Frequency of vascular and pregnancy morbidity in patients with low vs. moderate-to-high titers of antiphospholipid antibodies.
Ofer-Shiber S; Molad Y
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):261-6. PubMed ID: 25526601
[TBL] [Abstract][Full Text] [Related]
10. Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study.
Bidot CJ; Horstman LL; Jy W; Jimenez JJ; Bidot C; Ahn YS; Alexander JS; Gonzalez-Toledo E; Kelley RE; Minagar A
BMC Neurol; 2007 Oct; 7():36. PubMed ID: 17945023
[TBL] [Abstract][Full Text] [Related]
11. Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis.
Harrison CN; Donohoe S; Carr P; Dave M; Mackie I; Machin SJ
Thromb Haemost; 2002 May; 87(5):802-7. PubMed ID: 12038780
[TBL] [Abstract][Full Text] [Related]
12. IgA antiphospholipid antibodies are an independent risk factor for thromboses.
Shen YM; Lee R; Frenkel E; Sarode R
Lupus; 2008 Nov; 17(11):996-1003. PubMed ID: 18852223
[TBL] [Abstract][Full Text] [Related]
13. The association of serum antiphospholipid antibodies and dilute Russell's viper venom times.
Froom P; Saffuri-Elias E; Rozenberg O; Barak M
J Clin Pathol; 2014 May; 67(5):441-4. PubMed ID: 24327661
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid antibodies and vitamin D deficiency in COVID-19 infection with and without venous or arterial thrombosis: A pilot case-control study.
Shah R; Mohammed YN; Koehler TJ; Kaur J; Toufeili M; Pulipati P; Alqaysi A; Khan A; Khalid M; Lee Y; Dhillon P; Dan AT; Kumar N; Bowen M; Sule AA; Krishnamoorthy G
PLoS One; 2022; 17(7):e0269466. PubMed ID: 35834511
[TBL] [Abstract][Full Text] [Related]
15. [Antiphospholipid syndrome and pregnancy].
Koleva R; Chernev T; Karag'ozova Zh; Dimitrova V
Akush Ginekol (Sofiia); 2004; 43(1):36-42. PubMed ID: 15168653
[TBL] [Abstract][Full Text] [Related]
16. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity.
Lackner KJ; von Landenberg C; Barlage S; Schmitz G
Thromb Haemost; 2000 Apr; 83(4):583-8. PubMed ID: 10780321
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylserine IgG and beta-2-glycoprotein I IgA antibodies may be a risk factor for ischaemic stroke.
Kahles T; Humpich M; Steinmetz H; Sitzer M; Lindhoff-Last E
Rheumatology (Oxford); 2005 Sep; 44(9):1161-5. PubMed ID: 15927998
[TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid antibodies in renal allograft recipients.
Furmańczyk-Zawiska A; Bączkowska T; Sadowska A; Szmidt J; Chmura A; Durlik M
Transplant Proc; 2013 May; 45(4):1655-60. PubMed ID: 23726642
[TBL] [Abstract][Full Text] [Related]
19. Thrombosis and Hyperinflammation in COVID-19 Acute Phase Are Related to Anti-Phosphatidylserine and Anti-Phosphatidylinositol Antibody Positivity.
Alijotas-Reig J; Anunciación-Llunell A; Morales-Pérez S; Trapé J; Esteve-Valverde E; Miro-Mur F
Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626797
[TBL] [Abstract][Full Text] [Related]
20. A case of Waldenstroem's disease with a monoclonal IgM antiphospholipid antibody.
von Landenberg P; Schölmerich J; Andreesen R; Vogelhuber M; Lackner KJ
Rheumatol Int; 2002 Jul; 22(3):129-31. PubMed ID: 12111091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
